X0201 4/A2003-09-302003-10-01 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001014156 WATTLETON FAYE 300 CENTRAL PARK WEST APT. 15H NEW YORK NY 10024 1000Common stock, $.01 par value per share2003-09-304A04955.05A3862DOptions to purchase common stock, $.01 par value per share5.052003-09-304A050005.05A2004-09-302013-09-30Common stock, $01 par value per share500085000DThese shares were granted pursuant to the Company's Stock Compensation Plan for Outside Directors, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $2,500, until he is no longer an Outside Director. On September 30, 2003, the fair market value of the Common Stock, based on the closing price, was $5.05.These options will become fully vested and immediately exercisable on 9/30/2004.This stock grant was originally reported in Table 1 Columns 3 and 4 with the incorrect transaction codes. The stock grant was originally reported in Column 3 as "D" instead of "A" and in Column 4 as "D" for securities disposed of instead of "A" for securities acquired. /s/ Faye Wattleton2004-01-14